CDK9 inhibitors (G1 Therapeutics)

N/A

Report date: 2025/01/26 17:58:26
NME

Base Information

Drug NameCDK9 inhibitors (G1 Therapeutics)
Drug Alias NameCDK9 inhibitors (G1 Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesG1 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesG1 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A